Effects of dacomitinib on the pharmacokinetics of poziotinib in vivo and in vitro

CONTEXT: Dacomitinib and poziotinib, irreversible ErbB family blockers, are often used for treatment of non-small cell lung cancer (NSCLC) in the clinic. OBJECTIVE: This study investigates the effect of dacomitinib on the pharmacokinetics of poziotinib in rats. MATERIALS AND METHODS: Twelve Sprague–...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Weiping, Shen, Jiquan, Wang, Bo, Chen, Feifei, Meng, Deru, Wang, Shuanghu, Dai, Dapeng, Zhou, Yunfang, Wang, Changxiong, Zhou, Quan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079061/
https://www.ncbi.nlm.nih.gov/pubmed/33899675
http://dx.doi.org/10.1080/13880209.2021.1914114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079061/
https://www.ncbi.nlm.nih.gov/pubmed/33899675
http://dx.doi.org/10.1080/13880209.2021.1914114

Ejemplares similares